Clinical Outcomes and Recurrence Predictors of Lymph Node Positive Urothelial Cancer After Cystectomy
Authors:
- 1 November 2009
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 182 (5) , 2182-2187
Abstract
Lymph node metastasis in patients who undergo radical cystectomy for bladder transitional cell carcinoma is considered a poor prognostic factor. However, patients with minimal lymph node involvement likely have a better outcome than those with extensive disease. We examined outcomes in patients with low volume lymph node metastasis and identified variables associated with disease recurrence. Our institution maintains a database of 1,600 patients with bladder transitional carcinoma who underwent radical cystectomy from 1971 to 2005 with intent to cure. All patients with low volume lymph node metastasis, defined as 1 or 2 positive lymph nodes, without concomitant distant metastasis were included in study. A total of 181 patients were identified. Median followup was 12.8 years, during which 96 patients experienced recurrence. Estimated 5 and 10-year recurrence-free survival was 43.8% and 40.9%, respectively. Multivariate analysis indicated that pathological stage/subgroup (RR 1.733, p = 0.015), lymph node density (RR 1.935, p = 0.014) and adjuvant chemotherapy (RR 0.538, p = 0.004) were significant independent predictors of recurrence-free survival. A considerable proportion of patients with low volume lymph node metastasis in our cohort remained free of recurrence during followup. Extravesical tumor extension and lymph node density greater than 4% were associated with a higher recurrence risk and adjuvant chemotherapy was associated with a lower risk. Although some patients with low volume lymph node metastasis may be cured by surgery alone, these data support adjuvant chemotherapy in these patients.Keywords
This publication has 13 references indexed in Scilit:
- Evaluation of the Relevance of Lymph Node Density in a Contemporary Series of Patients Undergoing Radical CystectomyJournal of Urology, 2006
- Risk Factors for Patients With Pelvic Lymph Node Metastases Following Radical Cystectomy With En Bloc Pelvic Lymphadenectomy: The Concept of Lymph Node DensityJournal of Urology, 2003
- Extent of Pelvic Lymphadenectomy and Its Impact On Outcome in Patients Diagnosed With Bladder Cancer: Analysis of Data From the Surveillance, Epidemiology and End Results Program Data BaseJournal of Urology, 2003
- Superiority of Ratio Based Lymph Node Staging for Bladder CancerJournal of Urology, 2003
- Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant TherapyJournal of Clinical Oncology, 2003
- PELVIC LYMPH NODE METASTASES FROM BLADDER CANCER: OUTCOME IN 83 PATIENTS AFTER RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMYJournal of Urology, 2001
- Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosisBJU International, 2000
- THE IMPACT OF PRIMARY STAGE ON SURVIVAL IN PATIENTS WITH LYMPH NODE POSITIVE BLADDER CANCERJournal of Urology, 1999
- The Rationale for EN Bloc Pelvic Lymph Node Dissection for Bladder Cancer Patients with Nodal Metastases: Long-Term ResultsJournal of Urology, 1993
- Management of Invasive Bladder Cancer: A Meticulous Pelvic Node Dissection Can Make a DifferenceJournal of Urology, 1982